A comparative analysis of the genome of nontoxigenic and toxigenic V. cholerae O1 El Tor strains identified in Russia in 2023 and their phylogenetic analys
1 June 2026 in Molecular Genetics, Microbiology and Virology
The aim of this study was to analyze the CRISPR-Cas system of V. cholerae serogroup O1 strains of the classical biovar and nontoxigenic isolates of the El
14 January 2026 in Problems of Particularly Dangerous Infections
The aim of the study was to obtain a cholera toxin B-subunit producer based on the avirulent probiotic strain Escherichia coli M-17 and to study its molecular-genetic and immunogenic properties. Materials and methods . The genetically marked E. coli KS164 thy polA (pIEM3) strain, containing a recombinant plasmid with the cloned ctxB gene encoding the B-subunit of cholera toxin, and the avirulent E. coli M-17 strain, applied for the production of colicontaining probiotics, were used. The strains were analyzed using various methods: molecular genetics, biochemistry, and immunology. Results and discussion . Through introducing the recombinant cointegrate plasmid pIEM3 (KmRTcR) with the cloned ctxB gene into E. coli M-17 cells via conjugation, KmRTcR transconjugants with high levels of secreted cholera toxin B-subunit production (10 μg/ml) were obtained. One of these transconjugants (KM147) was used as the producer strain for the protective antigen. It was demonstrated that the constructed E. coli strain KM147(pIEM3) KmRTcR stably inherits the cloned ctxB gene contained in the recombinant plasmid, is capable of producing antitoxic antibodies in immunized animals, and safe for the use in model animals. These properties combined make it promising for future use in the development of prophylactic and diagnostic cholera drugs.